Immunomodulation: A new horizon for medicaltreatment of heart failure
References (37)
- et al.
Evaluation of postmortem endomyocardial biopsy specimen from 38 patients with lymphocytic myocarditis: Implication for role of sampling error
- et al.
Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy
Lancet
(1986) - et al.
Inhibition of cytokine production by a new inotropic agent, vesnarinone, in human lymphocytes, T cell line, and monocytic cell line
Life Sciences
(1994) - et al.
Inotropic agent vesnarinone inhibits cytokine production and Eselection expression in human umbilical vein endothelial cells
J Mol Cell Cardiol
(1995) - et al.
Viral infection and the pathogenesis of dilated cardiomyopathy
Circ Res
(1994) - et al.
A case of biopsy-proven myocarditis progressing to autopsy-proven dilated cardiomyopathy
Clin Cardiol
(1990) Virological study of idiopathic cardiomyopathy: serological study of virus antibodies and immunofluorescent study of myocardial biopsies
Jpn Circ J
(1981)- et al.
Routine use of β-antibody-capture ELISA for the serological diagnosis of coxsackie B virus infections
J Med Virol
(1986) - et al.
Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy
Circulation
(1994) - et al.
Cardiac persistence of cardioviral RNA detected by polymerase chain reaction in a murine model of dilated cardiomyopathy
Circulation
(1992)
Dilated cardiomyopathy associated with hepatitis C virus infection
Circulation
(1995)
Animal models: pathological findings and therapeutic considerations
Coxsackievirus B-3 myocarditis: acute and chronic forms of the disease caused by different immuno pathogenic mechanisms
Am J Pathol
(1987)
Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis
J Immunol
(1986)
Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease
J Immunol
(1974)
Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
N Engl J Med
(1990)
Mechanisms of immune-mediated myocyte injury
Circulation
(1994)
Increased circulating cytokines in patients with myocarditis and cardiomyopathy
Br Heart J
(1994)
Cited by (23)
Orosomucoid: A mortality risk factor in elderly people living in the community?
2002, Clinical NutritionThe underreporting of results and possible mechanisms of 'negative' drug trials in patients with chronic heart failure
2001, International Journal of CardiologyThe role of inflammatory mediators in chronic heart failure: Cytokines, nitric oxide, and endothelin-1
2000, International Journal of CardiologyThe changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy
1999, International Journal of Cardiology
Copyright © 1996 Published by Elsevier Inc.